Alexandre R. Zlotta, MD, PHD, FRCSC

Disclosure information not submitted.

Presentation(s):

• PD26-05: How long should we follow low grade Ta non-muscle invasive bladder cancer (NMIBC)? A large retrospective single institution analysis

  Saturday, May 14, 2022
  1:40 PM – 1:50 PM

• PD42-01: Propensity matched comparison of radical cystectomy with trimodality therapy for muscle invasive bladder cancer (MIBC): a multi-institutional study

  Sunday, May 15, 2022
  9:30 AM – 9:40 AM